-+ 0.00%
-+ 0.00%
-+ 0.00%

Stoke Therapeutics grants 129,565 inducement stock options to new employees at $35.54/share

PUBT·04/16/2026 20:01:40
Listen to the news
Stoke Therapeutics grants 129,565 inducement stock options to new employees at $35.54/share
  • Stoke Therapeutics granted stock options covering 129,565 common shares to 14 new employees, effective April 15, 2026.
  • Options carry an exercise price of USD 35.54 per share.
  • Vesting runs over four years, with 25% vesting after one year.
  • Remaining vesting occurs monthly over the next 36 months, subject to continued employment.
  • Options have a 10-year term under Stoke’s 2023 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604161601BIZWIRE_USPR_____20260416_BW221650) on April 16, 2026, and is solely responsible for the information contained therein.